Animal models for COVID-19

被引：594

作者：

Munoz-Fontela, Cesar ^{[1
,2
]}

Dowling, William E. ^{[3
]}

Funnell, Simon G. P. ^{[4
]}

Gsell, Pierre-S. ^{[5
]}

Riveros-Balta, A. Ximena ^{[5
]}

Albrecht, Randy A. ^{[6
]}

Andersen, Hanne ^{[7
]}

Baric, Ralph S. ^{[8
]}

Carroll, Miles W. ^{[4
]}

Cavaleri, Marco ^{[9
]}

Qin, Chuan ^{[10
]}

Crozier, Ian ^{[11
]}

Dallmeier, Kai ^{[12
]}

de Waal, Leon ^{[13
]}

de Wit, Emmie ^{[14
]}

Delang, Leen ^{[12
]}

Dohm, Erik ^{[15
]}

Duprex, W. Paul ^{[16
]}

Falzarano, Darryl ^{[17
]}

Finch, Courtney L. ^{[18
]}

Frieman, Matthew B. ^{[19
]}

Graham, Barney S. ^{[20
]}

Gralinski, Lisa E. ^{[8
]}

Guilfoyle, Kate ^{[13
]}

Haagmans, Bart L. ^{[21
]}

Hamilton, Geraldine A. ^{[22
]}

Hartman, Amy L. ^{[16
]}

Herfst, Sander ^{[21
]}

Kaptein, Suzanne J. F. ^{[12
]}

Klimstra, William B. ^{[23
]}

Knezevic, Ivana ^{[5
]}

Krause, Philip R. ^{[24
]}

Kuhn, Jens H. ^{[18
]}

Le Grand, Roger ^{[25
]}

Lewis, Mark G. ^{[7
]}

Liu, Wen-Chun ^{[6
]}

Maisonnasse, Pauline ^{[25
]}

McElroy, Anita K. ^{[26
]}

Munster, Vincent ^{[14
]}

Oreshkova, Nadia ^{[27
]}

Rasmussen, Angela L. ^{[28
]}

Rocha-Pereira, Joana ^{[12
]}

Rockx, Barry ^{[21
]}

Rodriguez, Estefania ^{[1
,2
]}

Rogers, Thomas F. ^{[29
]}

Salguero, Francisco J. ^{[4
]}

Schotsaert, Michael ^{[6
]}

Stittelaar, Koert J. ^{[13
]}

Jan Thibaut, Hendrik ^{[12
]}

Tseng, Chien-Te ^{[30
]}

机构：

[1] Bernhard Nocht Inst Trop Med, Hamburg, Germany

[2] German Ctr Infect Res DZIF, Partner Site Hamburg Lubeck Borstel Riems, Hamburg, Germany

[3] Ctr Epidem Preparedness Innovat CEPI, Washington, DC USA

[4] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England

[5] WHO, Geneva, Switzerland

[6] Icahn Sch Med Mt Sinai, Dept Microbiol, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA

[7] Bioqual Inc, Rockville, MD USA

[8] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA

[9] European Med Agcy, Amsterdam, Netherlands

[10] Chinese Acad Med Sci & Peking Union Med Coll, Inst Lab Anim Sci, Beijing, Peoples R China

[11] Frederick Natl Lab Canc Res, Clin Monitoring Res Program Directorate, Frederick, MD USA

[12] Katholieke Univ Leuven, Rega Inst, Lab Virol & Chemotherapy, Dept Microbiol Immunol & Transplantat, Leuven, Belgium

[13] Viroclin Xplore, Schaijk, Netherlands

[14] NIAID, Lab Virol, NIH, Hamilton, MT USA

[15] Univ Alabama Birmingham, Anim Resources Program, Birmingham, AL USA

[16] Univ Pittsburgh, Dept Microbiol & Mol Genet, Ctr Vaccine Res, Pittsburgh, PA USA

[17] Univ Saskatchewan, VIDO Intervac, Saskatoon, SK, Canada

[18] NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD USA

[19] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA

[20] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

[21] Erasmus MC, Dept Virosci, Rotterdam, Netherlands

[22] Emulate Inc, Boston, MA USA

[23] Univ Pittsburgh, Dept Immunol, Ctr Vaccine Res, Pittsburgh, PA USA

[24] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA

[25] Univ Paris Saclay, Ctr Immunol Viral Autoimmune Hematol & Bacterial, INSERM, CEA, Paris, France

[26] Univ Pittsburgh, Sch Med, Div Pediat Infect Dis, Ctr Vaccine Res, Pittsburgh, PA USA

[27] Wageningen Univ & Res, Wageningen Biovet Res WBVR, Lelystad, Netherlands

[28] Columbia Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY USA

[29] Univ Calif San Diego, Div Infect Dis, San Diego, CA 92103 USA

[30] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA

[31] Campus Univ Autonoma Barcelona, Ctr Recerca Sanitat Anim CReSA, IRTA UAB, Bellaterra, Spain

[32] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany

[33] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Carol Yu Ctr Infect, Hong Kong, Peoples R China

[34] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA USA

[35] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA

[36] Tulane Natl Primate Res Ctr, Covington, LA USA

[37] UAB, Fac Vet, Dept Sanitat & Anat Anim, Bellaterra, Spain

[38] CSIRO, Australian Ctr Dis Preparedness, Geelong, Vic, Australia

[39] Univ York, Dept Hlth Sci, York, N Yorkshire, England

[40] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA

来源：

NATURE | 2020年 / 586卷 / 7830期

关键词：

RESPIRATORY SYNDROME CORONAVIRUS; MOUSE MODEL; SARS; INFECTION; MICE; SARS-COV-2; MERS; PATHOGENESIS; RESERVOIRS; EFFICACY;

D O I：

10.1038/s41586-020-2787-6

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the aetiological agent of coronavirus disease 2019 (COVID-19), an emerging respiratory infection caused by the introduction of a novel coronavirus into humans late in 2019 (first detected in Hubei province, China). As of 18 September 2020, SARS-CoV-2 has spread to 215 countries, has infected more than 30 million people and has caused more than 950,000 deaths. As humans do not have pre-existing immunity to SARS-CoV-2, there is an urgent need to develop therapeutic agents and vaccines to mitigate the current pandemic and to prevent the re-emergence of COVID-19. In February 2020, the World Health Organization (WHO) assembled an international panel to develop animal models for COVID-19 to accelerate the testing of vaccines and therapeutic agents. Here we summarize the findings to date and provides relevant information for preclinical testing of vaccine candidates and therapeutic agents for COVID-19. The findings of a World Health Organization expert working group that is developing animal models to test vaccines and therapeutic agents for the treatment of COVID-19, and their relevance for preclinical testing, are reviewed.

引用

页码：509 / 515

页数：7

共 50 条

[21] Animal Models for COVID-19 Therapeutic Development: Where We Are and Where We Need to Go
Zhao, Sihai
Fan, Jianglin
Liu, Enqi
FRONTIERS IN MICROBIOLOGY, 2022, 13
[22] Genetically modified mouse models to help fight COVID-19
Gurumurthy, Channabasavaiah B.
Quadros, Rolen M.
Richardson, Guy P.
Poluektova, Larisa Y.
Mansour, Suzanne L.
Ohtsuka, Masato
NATURE PROTOCOLS, 2020, 15 (12) : 3777 - 3787
[23] Potential Neurologic Manifestations of COVID-19
Nordvig, Anna S.
Fong, Kathryn T.
Willey, Joshua Z.
Thakur, Kiran T.
Boehme, Amelia K.
Vargas, Wendy S.
Smith, Craig J.
Elkind, Mitchell S., V
NEUROLOGY-CLINICAL PRACTICE, 2021, 11 (02) : E135 - E146
[24] Pregnancy and COVID-19: management and challenges
Yao Wenling
Qiu Junchao
Xiao Zhirong
Ouyang Shi
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2020, 62 : 1 - 9
[25] Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses
Awad, Ahmed M.
Hansen, Kamryn
Del Rio, Diana
Flores, Derek
Barghash, Reham F.
Kakkola, Laura
Julkunen, Ilkka
Awad, Kareem
BIOMOLECULES, 2023, 13 (10)
[26] Animal models for studying covid-19, prevention, and therapy: Pathology and disease phenotypes
Choudhary, Shambhunath
Kanevsky, Isis
Tomlinson, Lindsay
VETERINARY PATHOLOGY, 2022, 59 (04) : 516 - 527
[27] Molnupiravir Revisited-Critical Assessment of Studies in Animal Models of COVID-19
Rasmussen, Henrik Berg
Hansen, Peter Riis
VIRUSES-BASEL, 2023, 15 (11):
[28] Zebrafish models of COVID-19
Tyrkalska, Sylwia D.
Candel, Sergio
Pedoto, Annamaria
Garcia-Moreno, Diana
Alcaraz-Perez, Francisca
Sanchez-Ferrer, Alvaro
Cayuela, Maria L.
Mulero, Victoriano
FEMS MICROBIOLOGY REVIEWS, 2023, 47 (01)
[29] COVID-19: a review
Madabhavi, Irappa
Sarkar, Malay
Kadakol, Nagaveni
MONALDI ARCHIVES FOR CHEST DISEASE, 2020, 90 (02) : 248 - 258
[30] COVID-19, SARS and MERS: A neurological perspective
Kwong, Koy Chong Ng Kee
Mehta, Puja R.
Shukla, Garima
Mehta, Arpan R.
JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 77 : 13 - 16

← 1 2 3 4 5 →